Ani Pharmaceuticals reported $322.4M in Current Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Aerie Pharmaceuticals AERI:US $ 311.41M 5.56M
Ani Pharmaceuticals ANIP:US $ 322.4M 21M
Aurora Cannabis Inc ACB:CN 745.12M 48.49M
Canopy Growth Corp WEED:CN C$ 1.59B 143.83M
Depomed DEPO:US $ 117.39M 7.73M
Eli Lilly And LLY:US $ 17115.2M 150.5M
Emergent Biosolutions EBS:US $ 1084.2M 16.1M
Endo International Ordinary Shares ENDP:US $ 2199.9M 292.89M
Heron Therapeutics HRTX:US $ 194.21M 28.38M
Hikma Pharmaceutical HIK:LN 176.1B 21.32B
Knight Therapeutics Inc GUD:CN C$ 320.35M 10.66M
Lannett LCI:US $ 290.12M 28.59M
Nektar Therapeutics NKTR:US $ 665.54M 67.92M
Novartis NVS:US $ 38142M 906M
Omeros OMER:US $ 192.72M 17.5M
Perrigo Ordinary Shares PRGO:US $ 2651.5M 1284M
Teva Pharmaceutical TEVA:IT 12.16B 287M
Teva Pharmaceutical Industries TEVA:US $ 12164M 287M